Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Chatelain

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Cardiovascular Pharmacology|December 5, 1997
Effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, CGS 30440, on blood pressure and cardiac hypertrophy in spontaneously hypertensive ratsR L Webb, M L Abramson, M E Beil, et al.
Cleveland Clinic Journal of Medicine|June 1, 1989
Malignant hypertension, fibrinoid deposition, and fibrinogen electrophoresisB N Dardik, J R Shainoff, R E Chatelain, et al.
Journal De Chirurgie|December 25, 2008
[The Main Gate Syndrome: a new format in mass-casualty victim "surge" management?]P Sockeel, C De Saint Roman, M-P Massoure, et al.
Journal De Chirurgie|June 22, 2006
[Pseudo-papillary tumor of the distal pancreas]P Michel, P David, E Chatelain, et al.
Biochimica Et Biophysica Acta|March 10, 1993
Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienolsE Chatelain, D O Boscoboinik, G M Bartoli, et al.
International Journal for Parasitology. Drugs and Drug Resistance|February 10, 2018
In vitro and in vivo pharmacodynamics of three novel antileishmanial lead seriesM Van den Kerkhof, D Mabille, E Chatelain, et al.
Molecular Pharmacology|April 16, 2003
Glucocorticoid receptor antagonism by cyproterone acetate and RU486Christian Honer, Kiyean Nam, Cynthia Fink, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11R E Chatelain, R D Ghai, A J Trapani, et al.
Metabolomics : Official Journal of the Metabolomic Society|August 24, 2019
Metabolomics, lipidomics and proteomics profiling of myoblasts infected with Trypanosoma cruzi after treatment with different drugs against Chagas diseaseK Hennig, J Abi-Ghanem, A Bunescu, et al.
Journal of Medicinal Chemistry|October 14, 2005
Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Gary M Coppola, Paivi J Kukkola, James L Stanton, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Cardiovascular Pharmacology|December 5, 1997
Effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, CGS 30440, on blood pressure and cardiac hypertrophy in spontaneously hypertensive ratsR L Webb, M L Abramson, M E Beil, et al.
Cleveland Clinic Journal of Medicine|June 1, 1989
Malignant hypertension, fibrinoid deposition, and fibrinogen electrophoresisB N Dardik, J R Shainoff, R E Chatelain, et al.
Journal De Chirurgie|December 25, 2008
[The Main Gate Syndrome: a new format in mass-casualty victim "surge" management?]P Sockeel, C De Saint Roman, M-P Massoure, et al.
Journal De Chirurgie|June 22, 2006
[Pseudo-papillary tumor of the distal pancreas]P Michel, P David, E Chatelain, et al.
Biochimica Et Biophysica Acta|March 10, 1993
Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienolsE Chatelain, D O Boscoboinik, G M Bartoli, et al.
International Journal for Parasitology. Drugs and Drug Resistance|February 10, 2018
In vitro and in vivo pharmacodynamics of three novel antileishmanial lead seriesM Van den Kerkhof, D Mabille, E Chatelain, et al.
Molecular Pharmacology|April 16, 2003
Glucocorticoid receptor antagonism by cyproterone acetate and RU486Christian Honer, Kiyean Nam, Cynthia Fink, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11R E Chatelain, R D Ghai, A J Trapani, et al.
Metabolomics : Official Journal of the Metabolomic Society|August 24, 2019
Metabolomics, lipidomics and proteomics profiling of myoblasts infected with Trypanosoma cruzi after treatment with different drugs against Chagas diseaseK Hennig, J Abi-Ghanem, A Bunescu, et al.
Journal of Medicinal Chemistry|October 14, 2005
Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Gary M Coppola, Paivi J Kukkola, James L Stanton, et al.
Pageof 4